Search

everythinglearnresearchcommunity

for

Search:↓

Keratin 19 helps identify skin stem cells, with its presence varying by body location, age, and culture stage.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

CK 19 expression is higher in more severe skin cancers.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Soluble CD83 speeds up wound healing and reduces scarring.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Human thymus has stem cells that can self-renew and maintain their identity.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

CD34 is crucial for skin tumor development in mice.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

CD44 variant changes start alopecia areata, but don't maintain it.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The method successfully created stable transfection donor cells for goat hair follicle research.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Targeting colon cancer stem cells might lead to better treatment results.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.